Apotex settles US states' claims over generic drugs for $39.1 million
MLex Summary: Apotex agreed to pay $39.1 million to settle allegations from state attorneys general that it conspired to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade regarding...To view the full article, register now.
Already a subscriber? Click here to view full article